BACKGROUND AND PURPOSE: Risk factors for acute ischemic stroke following flow-
diverter treatment of intracranial aneurysms are poorly understood. Using the International …

BACKGROUND AND PURPOSE: Spontaneous intraparenchymal hemorrhage is a dreaded
complication of unknown etiology following flow-diversion treatment. Using the International …

BACKGROUND AND PURPOSE: Flow diversion with the Pipeline Embolization Device
(PED) for the treatment of intracranial aneurysms is associated with a high rate of aneurysm …

OBJECTIVE The aim of this study was to compare the clinical and angiographic outcomes of
intracranial aneurysms with and without branches arising from the sac after Pipeline …

Purpose To evaluate the midterm clinical and angiographic outcomes after pipeline
embolization device (PED) placement for treatment of intracranial aneurysms. Materials and …

Abstract Background and Objective: Few prospective studies exist evaluating the safety and
efficacy of the Pipeline Embolization Device (PED) in the treatment of intracranial …

BACKGROUND: The Pipeline embolization device (PED) is the latest technology available
for intracranial aneurysm treatment. OBJECTIVE: To report early postmarket results with the …

BACKGROUND AND PURPOSE: The Pipeline Embolization Device has emerged as an
important treatment option for intracranial aneurysms. The number of devices needed to …

BACKGROUND: The Pipeline Embolization Device (PED) has emerged as a promising
treatment for intracranial aneurysms. OBJECTIVE: To assess the safety and efficacy of the …

BACKGROUND The Pipeline Embolization Device (PED; Medtronic, Dublin, Ireland) has
become an important tool for the treatment of cerebral aneurysms. Since FDA approval …